Clinical studies with fetal hemoglobin-enhancing agents in sickle cell diseaseSAUNTHARARAJAH, Yogen; DESIMONE, Joseph.Seminars in hematology. 2004, Vol 41, Num 4, pp 11-16, issn 0037-1963, 6 p., SUP6Conference Paper

DNA hypo-methylating agents and sickle cell diseaseSAUNTHARARAJAH, Yogen; LAVELLE, Donald; DESIMONE, Joseph et al.British journal of haematology. 2004, Vol 126, Num 5, pp 629-636, issn 0007-1048, 8 p.Article

Oligoclonal T cell expansion in myelodysplastic syndrome : evidence for an autoimmune processEPPERSON, Diane E; NAKAMURA, Ryotaro; SAUNTHARARAJAH, Yogen et al.Leukemia research. 2001, Vol 25, Num 12, pp 1075-1083, issn 0145-2126Article

Differential effects of low-dose decitabine on immune effector and suppressor responses in melanoma-bearing miceTRIOZZI, Pierre L; ALDRICH, Wayne; ACHBERGER, Susan et al.Cancer immunology and immunotherapy. 2012, Vol 61, Num 9, pp 1441-1450, issn 0340-7004, 10 p.Article

Modification of hematopoietic stem cell fate by 5aza 2'deoxycytidine and trichostatin AMILHEM, Mohammed; MAHMUD, Nadim; LAVELLE, Donald et al.Blood. 2004, Vol 103, Num 11, pp 4102-4110, issn 0006-4971, 9 p.Article

Epigenetic regulation by decitabine of melanoma differentiation in vitro and in vivoALCAZAR, Oscar; ACHBERGER, Susan; ALDRICH, Wayne et al.International journal of cancer (Print). 2012, Vol 131, Num 1, pp 18-29, issn 0020-7136, 12 p.Article

A simple method to predict response to immunosuppressive therapy in patients with myelodysplastic syndromeSAUNTHARARAJAH, Yogen; NAKAMURA, Ryotaro; WESLEY, Robert et al.Blood. 2003, Vol 102, Num 8, pp 3025-3027, issn 0006-4971, 3 p.Article

HLA-DR4 predicts haematological response to cyclosporine in T-large granular lymphocyte lymphoproliferative disordersBATTIWALLA, Minoo; MELENHORST, Jos; SAUNTHARARAJAH, Yogen et al.British journal of haematology. 2003, Vol 123, Num 3, pp 449-453, issn 0007-1048, 5 p.Article

Monosomy 3 by FISH in Uveal Melanoma: Variability in Techniques and ResultsARONOW, Mary; YANG SUN; SAUNTHARARAJAH, Yogen et al.Survey of ophthalmology. 2012, Vol 57, Num 5, pp 463-473, issn 0039-6257, 11 p.Article

Noncytotoxic Differentiation Treatment of Renal Cell CancerNEGROTTO, Soledad; ZHENBO HU; ALCAZAR, Oscar et al.Cancer research (Chicago, Ill.). 2011, Vol 71, Num 4, pp 1431-1441, issn 0008-5472, 11 p.Article

RUNX1 regulates corepressor interactions of PU.1ZHENBO HU; XIAORONG GU; BARAOIDAN, Kristine et al.Blood. 2011, Vol 117, Num 24, pp 6498-6508, issn 0006-4971, 11 p.Article

Aberrant DNA methylation is a dominant mechanism in MDS progression to AMLYING JIANG; DUNBAR, Andrew; GONDEK, Lukasz P et al.Blood. 2009, Vol 113, Num 6, pp 1315-1325, issn 0006-4971, 11 p.Article

AML1-ETO decreases ETO-2 (MTG16) interactions with nuclear receptor corepressor, an effect that impairs granulocyte differentiationIBANEZ, Vinzon; SHARMA, Arun; BUONAMICI, Silvia et al.Cancer research (Baltimore). 2004, Vol 64, Num 13, pp 4547-4554, issn 0008-5472, 8 p.Article

SF3B1 haploinsufficiency leads to formation of ring sideroblasts in myelodysplastic syndromesVISCONTE, Valeria; ROGERS, Heesun J; JEREZ, Andres et al.Blood. 2012, Vol 120, Num 16, pp 3173-3186, issn 0006-4971, 14 p.Article

Brief report A pilot study of subcutaneous decitabine in β-thalassemia intermediaOLIVIERI, Nancy F; SAUNTHARARAJAH, Yogen; THAYALASUTHAN, Vivek et al.Blood. 2011, Vol 118, Num 10, pp 2708-2711, issn 0006-4971, 4 p.Article

Effects of tetrahydrouridine on pharmacokinetics and pharmacodynamics of oral decitabineLAVELLE, Donald; VAITKUS, Kestis; COVEY, Joseph et al.Blood. 2012, Vol 119, Num 5, pp 1240-1247, issn 0006-4971, 8 p.Article

Oral decitabine reactivates expression of the methylated γ-globin gene in Papio anubisLAVELLE, Donald; CHIN, Janet; SAUNTHARARAJAH, Yogen et al.American journal of hematology. 2007, Vol 82, Num 11, pp 981-985, issn 0361-8609, 5 p.Article

Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia risks and benefits up to 9 years of treatmentSTEINBBERG, Martin H; BARTON, Franca; VARMA, Mala et al.JAMA, the journal of the American Medical Association. 2003, Vol 289, Num 13, pp 1645-1651, issn 0098-7484, 7 p.Article

p53-Independent, Normal Stem Cell Sparing Epigenetic Differentiation Therapy for Myeloid and Other Malignancies : MOLECULAR PATHOGENESIS OF HEMATOLOGIC MALIGNANCIESSAUNTHARARAJAH, Yogen; TRIOZZI, Pierre; COPELAN, Ed et al.Seminars in oncology. 2012, Vol 39, Num 1, pp 97-108, issn 0093-7754, 12 p.Article

HLA-DR15 (DR2) is overrepresented in myelodysplastic syndrome and aplastic anemia and predicts a response to immunosuppression in myelodysplastic syndromeSAUNTHARARAJAH, Yogen; NAKAMURA, Ryotaro; NAM, Jun-Mo et al.Blood. 2002, Vol 100, Num 5, pp 1570-1574, issn 0006-4971, 5 p.Article

Coincident myelodysplastic syndrome and T-cell large granular lymphocytic disease : clinical and pathophysiological featuresSAUNTHARARAJAH, Yogen; MOLLDREM, Jefferey J; RIVERA, Mary et al.British journal of haematology. 2001, Vol 112, Num 1, pp 195-200, issn 0007-1048Article

Risk for Developing Myelodysplastic Syndromes in Prostate Cancer Patients Definitively Treated With RadiationMUKHERJEE, Sudipto; REDDY, Chandana A; MACIEJEWSKI, Jaroslaw P et al.Journal of the National Cancer Institute. 2014, Vol 106, Num 3, issn 0027-8874, 1.1-1.12Article

Patient-Reported Outcomes: Descriptors of Nociceptive and Neuropathic Pain and Barriers to Effective Pain Management in Adult Outpatients With Sickle Cell DiseaseWILKIE, Diana J; MOLOKIE, Robert; BOYD-SEAL, Debra et al.Journal of the National Medical Association. 2010, Vol 102, Num 1, pp 18-27, issn 0027-9684, 10 p.Article

Increased frequency of HLA-DR2 in patients with paroxysmal nocturnal hemoglobinuria and the PNH/aplastic anemia syndromeMACIEJEWSKI, Jaroslaw P; FOLLMANN, Dean; NAKAMURA, Ryotaro et al.Blood. 2001, Vol 98, Num 13, pp 3513-3519, issn 0006-4971Article

Increased CDA Expression/Activity in Males Contributes to Decreased Cytidine Analog Half-Life and Likely Contributes to Worse Outcomes with 5-Azacytidine or Decitabine TherapyMAHFOUZ, Reda Z; JANKOWSKA, Ania; ENGELKE, Kory J et al.Clinical cancer research (Print). 2013, Vol 19, Num 4, pp 938-948, issn 1078-0432, 11 p.Article